INPHASOL INC.
Phagineering the gut microbiome: Bacteriophages to reduce Desulfovibrio spp. and hydrogen sulfide in the intestine
Phagineering the gut microbiome: Bacteriophages to reduce Desulfovibrio spp. and hydrogen sulfide in the intestine is a funding opportunity from INPHASOL INC., up to 178026, closing August 31, 2027.
Aug 31, 2027
(396d left)Overview
Project Summary The excessive production of hydrogen sulfide (H2S) gas has been implicated in a number of health conditions including ulcerative colitis, Crohn’s disease, and colon rectal cancer due to its toxicity and inflammatory properties. While these associations have not been shown to be definitively…